COMPOSITIONS AND METHODS OF MODULATING THE TASTE AND SMELL RECEPTORS AND SCREENING METHODS THEREFORE

• US 20100215584A1
• Filed: 11/29/2006
• Published: 08/26/2010
• Est. Priority Date: 11/30/2005
• Status: Abandoned Application

• Current Assignee: Axitare, Inc.
• Original Assignee: Axitare, Inc.
• Inventors: Passe, James G.
• Application Number:
  US12/095,529
• Publication Number:
  US 20100215584A1
• Time in Patent Office: Days
• US Class Current: 424/9.200
• CPC Class Codes: C07K 14/705 Receptors; Cell surface antigens; Cell surface determinants tumour specific antigens C07K14/4748

Abstract

The present invention relates to modulation of the perception of either taste or smell through modulation of the activity of GRKs which regulate the desensitization process of the taste and smell receptors. By the process of either inhibiting or enhancing GRK activity at the receptor site a modulation in perception of taste and smell can be achieved. The invention discloses methods of treatment as well as methods of discovering compounds useful in the invention. The invention further discloses methods of treating eating disorders or obesity using compositions of the type disclosed in the invention.

Claims

1. A method for modulation of the perception of taste or smell in a subject comprising administering to the subject an effective amount of a formulation which contains a composition which inhibits the activity of a GRK protein directly to the tongue or the nose sufficient to effect a perceptible modulation of taste or smell.

2. A method according to claim 1 wherein the GRK is selected from the group consisting of GRK2, GRK3, GRK5 or GRK6.

3. A method according to claim 1 wherein the composition is applied to the tongue.

4. A method according to claim 1 wherein the composition is applied to the nasal cavity.

5. A formulation for modulating the perception of taste or smell comprising a composition which inhibits the activity of GRK formulated for administration directly to the taste receptors on the tongue or the smell receptors in the nose.

6. A formulation according to claim 5 wherein the formulation is formulated for application intranasally.

7. A formulation according to claim 5 wherein the formulation is formulated for application to the tongue.

8. A formulation according to claim 5 which has been formulated to minimize systemic absorption of the composition.

9. A food or an odorant to which has been added a GRK modulator sufficient to modulate a subject'"'"'s perception of a taste or smell of the food or odorant when consumed.

10. An odorant according to claim 9 which is a perfume.

11. A food according to claim 9 which is an animal feed.

12. A food according to claim 9 which is intended for human consumption.

13. an odorant according to claim 9 which is intended for human perception.

14. A method of reducing the amount of food consumed in a subject comprising administering a GRK modulator which enhances unpleasant taste or smell.

15. A method according to claim 14 wherein the subject is a human bitter taste in enhanced.

16. A method according to claim 14 wherein the subject is an insect.

17. A method of screening for compounds capable of modulating taste or smell comprising:

a) selecting a composition which inhibits the activity of GRK;

b) administering the composition to a test subject such that GRK in the vicinity of the taste or smell receptors is inhibited;

c) determining if the administration of the composition modulates the subject'"'"'s perception of smell or taste; and

d) selecting compounds which exhibit modulation of smell or taste.

18. A method according to claim 17 wherein the composition is administered directly to the smell receptors in the nose.

19. A method according to claim 17 wherein the composition is administered directly to the taste receptors on the tongue.

20. A method according to claim 17 which further comprises the steps of:

a) determining if the level of systemic absorption of the composition; and

b) selecting those compositions which modulate taste or smell and which do not exhibit significant systemic absorption.